Regadenoson
NDC 60505-6116, regadenoson, injection, solution, from Apotex Corp..
- Product NDC
- 60505-6116
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207604
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6116 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6116-0 | 60505611600 | 1 SYRINGE, PLASTIC in 1 CARTON (60505-6116-0) / 5 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/af131207-097f-3901-e711-fba004944076Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=60505-6116
Use it
Look up 60505-6116 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6116 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6116. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.